“ Adherence and Or Discontinuation of Imatinib Mesylate in Patients With Chronic Myeloid Leukemia ”. Brazilian Journal of Pharmaceutical Sciences, vol. 52, no. 4, Dec. 2016, pp. 581-9, https://doi.org/10.1590/s1984-82502016000400001.